Abstract
The preparation of arylmethoxysubstitutedphenyl acetic acid derivatives and their use as effective agents to inhibit leukotrienes are claimed. The three patent applications cover related compounds in a series of inhibitors that has been well studied by Bayer [1]. The compounds are stated to be useful in treating several diseases of allergy and inflammation that are often associated with leukotrienes. Biological data are limited to inhibition of LTB4 in calcium ionophore stimulated human PMNL and is included for only a few selected compounds. Most of the synthetic chemistry used for their preparation is standard, however, some methodology has been developed for the introduction of substituents on the central phenyl ring.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
